Skip to content
Home/Companies/HealthTech/Thirty Madison

Thirty Madison

HealthTech·United States·Exited 2025·Held 7yr
Entry
2018
Hold
7yr
Exit
2025

Who owns Thirty Madison?

Thirty Madison is an American HealthTech company, now owned by Remedy Meds, which acquired it in 2025 from Northzone Ventures.

Hand-verified · updated 2026-08-18

Open JSON · CC-BY
Northzone Ventures
Investor
Northzone Ventures
Northzone VII · 2016 · VC

Key facts

HQUnited States
SectorHealthTech
StatusActive
Exit Type
Trade Sale
Buyer
Remedy Meds
Exit Year
2025

More from Northzone VII

Other portfolio companies in the same fund.

Anyfin
Anyfin
Active
FintechSweden· 2018
Bunch
Bunch
Active
FintechGermany· 2018
Klang
Active
GamingGermany· 2018
Nested
Nested
Active
PropTechUK· 2018
Red Points
Red Points
Active
SaaSSpain· 2018
TIER
Active
MobilityGermany· 2018

More PE-backed in HealthTech

Comparable healthtech deals from other GPs.

52North Health
52North Health
Active
Future Planet CapitalUK
A Place for Mom
A Place for Mom
Active
Silver LakeUS
Advance Medical
Active
Summit PartnersUS
AdvancedMD
AdvancedMD
Active
Francisco PartnersUS
Agilio Software
Agilio Software
Active
TA AssociatesUS
agilon health
agilon health
Active
CD&RUS

Questions

Who owns Thirty Madison?

Thirty Madison is now owned by Remedy Meds, which acquired it in 2025 from Northzone Ventures.

When did Remedy Meds acquire Thirty Madison?

Remedy Meds acquired Thirty Madison in 2025, buying from Northzone Ventures.

Who did Thirty Madison sell to?

Northzone Ventures sold Thirty Madison to Remedy Meds in 2025 (Trade Sale).

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue